High Vista Strategies LLC Kinnate Biopharma Inc. Transaction History

High Vista Strategies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$7.73 - $17.99 $357,620 - $832,289	-46,264 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$16.5 - $25.48 $241,576 - $373,052	-14,641 Reduced 24.04%	46,264 $820,000
Q3 2021 Nov 15, 2021	BUY	$17.81 - $24.87 $490,024 - $684,273	27,514 Added 82.4%	60,905 $1.4 Million
Q2 2021 Aug 16, 2021	BUY	$22.19 - $31.55 $740,946 - $1.05 Million	33,391 New	33,391 $777,000

32.9M

94.7K

802K

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.